Close Nav

Publication of the Quarter

ASDR Publication of the Quarter Awards

In celebration of the pioneering work of ASDR members

Every quarter, we invite members to nominate their articles (published online or in print) for recognition.

Eligibility

  • Must be a current ASDR member

Application Process

  • Nominations are considered for the categories:
    • Ordinary Member
    • Student / Trainee / ECR Member (within 5 years of PhD conferral)

Applicants are to please:

  1. Email [email protected] with the subject line "Publication of the Quarter".
  2. Include a link to the publication.
  3. State the date of e-publication or in-print publication.
  4. State their name and confirm they are an ASDR member.
  5. Specify which award category they wish to be considered for: Ordinary or Student /Trainee/ECR

Assessment Criteria

  • Awardees are selected based on the scientific excellence of their paper

Value

  • $100 award for the Ordinary Member category
  • $100 award for the Student / Trainee / ECR Member category

Former Publication of the Quarter Awardees

2024

Timothy Cowan; Phenotypic differences in intermediate generalized junctional epidermolysis bullosa with homozygous LAMC2 mutation and a potential genetic modifier

Ellie Maas; 
POT1 and multiple primary melanomas: the dermatological phenotype

Ailin He; 
Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid-induced myopathy

Samuel X Tan; Automated scoring of tumor-infiltrating lymphocytes informs risk of death from thin melanoma: A nested case-case study

2023

Courtney Wallingford; The MC1R r allele does not increase melanoma risk in MITF E318K carriers
Lifeng Kang; Prediction of drug permeation through microneedled skin by machine learning
Katie Lee; The Skin Molecular Ecosystem Holds the Key to Nevogenesis and Melanomagenesis
Runqiu Song; A tactile approach to introduce the skin autoimmune disease psoriasis to the general public and the vision-impaired community

2022

Ge Peng; Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments
Ho Yi Wong; Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: A randomized, double-blind, placebo-controlled pilot trial
Mei Fong; Ngl Heterogeneity in Melanoma
Anna Wilson; Defining the incidence of cutaneous squamous cell carcinoma in coastal NSW Australia

2021

Nikolas Haass; Quantitative analysis of tumour spheroid structure
Anna Wilson; Clinical features of chronic bullous dermatosis of childhood